Who we are

Cambridge Phenotyping Limited is a high-tech start-up from Cambridge University aiming to transform pre-clinical and basic science research on cognition and behavior. It is led by world experts in neuroscience and engineering. We have developed advanced proprietary technology to deliver 21st century solutions to animal cognitive and behavior phenotyping. We take our approach to the next level by developing analogous tests in humans to facilitate translational relevance in pre-clinical and basic applications.
we have created solutions for pre-clinical experimentation without human bias. We deliver game-changing technologies by dramatically improving specificity, reliability, and animal welfare standards at lower costs.
We constantly augment   our products and services by working closely with our customers and partners.

Meet our Team and Advisory Board

Julija Krupic

Julija Krupic

CEO, CO-FOUNDER, PhD in Neuroscience

One of the leading scientists in spatial memory and navigation (published in Nature and Science) is on the Science Magazine Editorial Board; Deep Dementia Phenotyping Network, the UK DRI forum and ARUK; receiver of Eppendorf Science Prize (2015), the Wellcome Trust Sir Henry Dale (2017) and DRI fellowships (2019).

At the University of Cambridge, she leads one of the few labs in the world combining cutting edge optical and electrophysiological techniques. Together with Dr Bauza, they co-developed several revolutionary behavior paradigms such as the Honeycomb maze (published in Nature) and the smart-Kage.

Marius Bauza

Marius Bauza

CTO, co-founder

Exceptionally strong background in computational techniques, experimental technology development and animal research with more than fifteen years of experience in software development, hardware control and AI-based computational techniques. He developed multiple experimental pipelines, such as a novel virtual reality system for animal research, adopted by multiple laboratories, including UCL, University of Cambridge, King’s College London, and the University of Hong Kong.

Dainius Macikenas

Dainius Macikenas

Business development. Ex-Pfizer, Vertex Pharmaceuticals

Dainius has over 20 years of experience in the pharmaceutical industry developing pharmaceutical materials (Pfizer Inc, Vertex Pharmaceuticals, etc.).
He is also educated in photography, graphic and web design. He maintains his own photography and video content creation business and has a proven record of accomplishment of growing business via innovative media solutions.

William Coral

William Coral

Head of Engineering

PhD in Automation and Robotics, master’s degree in control systems. For over a decade he has developed bio-inspired and biomimetic robotics – soft robots using smart materials, that were exhibited at the Natural Science Museum of London and published in scientific journals. He has multiple patents in the areas of Agricultural Robotics, head and neck surgery and health care. he innovation leader of the first public-private centre for research and innovation in the Internet of Things (IoT) in Colombia, was a CTO and director of the mechatronics engineering department.


Hinze Ho

Hinze Ho

Advisor - Product Testing and Development

Hinze has BSc in biomedical science and MSc in neuroscience. His passion lies in understanding the neural mechanisms underpinning cognition and behaviors. He is keen on translating basic research findings into applicable solutions for biomedical problems.
In his free time, Hinze enjoys practicing art and design. Working as a freelance illustrator, he strives to create connections between topics of art and science.


Scientific Advisory Board

John O’Keefe

Nobel Prize winner in Physiology and Medicine, Professor of Neuroscience at University College London

John O’Keefe has discovered place cells and outlined the theory of the hippocampal function as the cognitive map. He has pioneered a number of the most influential techniques in neuroscience, including in vivo multi-tetrode neural recording, Neuropixels probes as well as behavioural tests for rodents and humans.

Frances Wiseman

UK DRI Programme Leader for Animal Models

Frances Wiseman investigates Alzheimer’s disease in individuals with Down syndrome. She completed a PhD researching Prion disease at the University of Edinburgh and is currently a group leader in UCL UK DRI. She has vast expertise in Down syndrome and animal models. For this, she was awarded the 3R prize for the reduction of animal use in 2016. She is also part of the London Down Syndrome Consortium – a large, multidisciplinary group of clinicians, human geneticists, developmental psychologists, mouse geneticists, psychiatrists and cellular scientists working towards understanding dementia in people with Down syndrome.

Dennis Chan

Principal Research Fellow of Metacognition and Executive Functions group, University College London

Dennis Chan is one of the research leads for the Alzheimer’s Research UK/Gates Ventures funded EDoN (Early Detection of Neurodegenerative Disease https://edon-initiative.org) initiative whose goal is to deliver digital tools capable of detecting AD and other disorders years before symptom onset in the general population, using wearable tech and AI respectively to deliver and analyze new datasets on cognition and everyday behaviour.
Away from UCL, Dennis works as a consultant neurologist and runs a cognitive disorders clinic in mid-Sussex with a special focus on patients with mild cognitive impairment and the emerging phenomenon of cognitive Covid.

Let's get in touch!


Block B, Imperial Works
Perren Street, London NW5 3ED
United Kingdom


M-S: 8 - 19
S: Closed